Home » Queston #17168Note

Queston #17168Note

Posted on December 6, 2022 by Benedict Hilado

Memantine MOA:
– NMDA receptor antagonist

Pimavanserin MOA:
– serotonin 5-HT receptor inverse agonism and antagonism
– approved for PD related psychosis

Follow on Social Media

Brian Hanrahan, MD & Steven Gangloff, MD

* RITE® is a registered trademark of the American Academy of Neurology (AAN) Institute. NowYouKnow Neuro™ (NYKN) is a preparatory resource for this and other neurology exams but is in no way affiliated with the RITE® exam, the AAN Institute, or the AAN. NYKN is in no way affiliated with the American Board of Psychiatry and Neurology (ABPN).